TY - JOUR
T1 - Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block
T2 - the PIRECNA multicentre registry
AU - Aksu, Tolga
AU - Piotrowski, Roman
AU - Tung, Roderick
AU - De Potter, Tom
AU - Markman, Timothy M.
AU - du Fay de Lavallaz, Jeanne
AU - Rekvava, Roin
AU - Alyesh, Daniel
AU - Joza, Jacqueline E.
AU - Badertscher, Patrick
AU - Do, Duc H.
AU - Bradfield, Jason S.
AU - Upadhyay, Gaurav
AU - Sood, Nitesh
AU - Sharma, Parikshit S.
AU - Guler, Tumer Erdem
AU - Gul, Enes Elvin
AU - Kumar, Vineet
AU - Koektuerk, Buelent
AU - Dal Forno, Alexander Romeno Janner
AU - Woods, Christopher E.
AU - Rav-Acha, Moshe
AU - Valeriano, Chiara
AU - Enriquez, Andres
AU - Sundaram, Sri
AU - Glikson, Michael
AU - d’Avila, Andre
AU - Shivkumar, Kalyanam
AU - Kulakowski, Piotr
AU - Huang, Henry D.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/7/1
Y1 - 2024/7/1
N2 - Aims Prior case series showed promising results for cardioneuroablation in patients with vagally induced atrioventricular blocks (VAVBs). We aimed to examine the acute procedural characteristics and intermediate-term outcomes of electroanatomical-guided cardioneuroablation (EACNA) in patients with VAVB. Methods This international multicentre retrospective registry included data collected from 20 centres. Patients presenting with symp- and results tomatic paroxysmal or persistent VAVB were included in the study. All patients underwent EACNA. Procedural success was defined by the acute reversal of atrioventricular blocks (AVBs) and complete abolition of atropine response. The primary outcome was occurrence of syncope and daytime second- or advanced-degree AVB on serial prolonged electrocardiogram monitoring during follow-up. A total of 130 patients underwent EACNA. Acute procedural success was achieved in 96.2% of the cases. During a median follow-up of 300 days (150, 496), the primary outcome occurred in 17/125 (14%) cases with acute procedural success (recurrence of AVB in 9 and new syncope in 8 cases). Operator experience and use of extracardiac vagal stimulation were similar for patients with and without primary outcomes. A history of atrial fibrillation, hypertension, and coronary artery disease was associated with a higher primary outcome occurrence. Only four patients with primary outcome required pacemaker placement during follow-up. Conclusion This is the largest multicentre study demonstrating the feasibility of EACNA with encouraging intermediate-term outcomes in selected patients with VAVB. Studies investigating the effect on burden of daytime symptoms caused by the AVB are required to confirm these findings.
AB - Aims Prior case series showed promising results for cardioneuroablation in patients with vagally induced atrioventricular blocks (VAVBs). We aimed to examine the acute procedural characteristics and intermediate-term outcomes of electroanatomical-guided cardioneuroablation (EACNA) in patients with VAVB. Methods This international multicentre retrospective registry included data collected from 20 centres. Patients presenting with symp- and results tomatic paroxysmal or persistent VAVB were included in the study. All patients underwent EACNA. Procedural success was defined by the acute reversal of atrioventricular blocks (AVBs) and complete abolition of atropine response. The primary outcome was occurrence of syncope and daytime second- or advanced-degree AVB on serial prolonged electrocardiogram monitoring during follow-up. A total of 130 patients underwent EACNA. Acute procedural success was achieved in 96.2% of the cases. During a median follow-up of 300 days (150, 496), the primary outcome occurred in 17/125 (14%) cases with acute procedural success (recurrence of AVB in 9 and new syncope in 8 cases). Operator experience and use of extracardiac vagal stimulation were similar for patients with and without primary outcomes. A history of atrial fibrillation, hypertension, and coronary artery disease was associated with a higher primary outcome occurrence. Only four patients with primary outcome required pacemaker placement during follow-up. Conclusion This is the largest multicentre study demonstrating the feasibility of EACNA with encouraging intermediate-term outcomes in selected patients with VAVB. Studies investigating the effect on burden of daytime symptoms caused by the AVB are required to confirm these findings.
KW - Ablation
KW - Atrioventricular block
KW - Bradycardia
KW - Ganglionated plexus
KW - Syncope
UR - http://www.scopus.com/inward/record.url?scp=85197510486&partnerID=8YFLogxK
U2 - 10.1093/europace/euae164
DO - 10.1093/europace/euae164
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38954426
AN - SCOPUS:85197510486
SN - 1099-5129
VL - 26
JO - Europace
JF - Europace
IS - 7
M1 - euae164
ER -